healthcare professional for medical advice
yellow eye
short term use of oral contraceptive
relative excess
edema
tooth disorder
mental depression
hepatocellular carcinoma in the united state
severe weakness
combine oral contraceptive on the risk of cervical adenocarcinoma
risk of gallbladder disease
heavy non menstrual vaginal bleeding
leg
cardiovascular
venous thromboembolism
stomach pain
oral contraceptive
urinary tract infection
acne
rash
dysmenorrhea
estrogen in oral contraceptive combination
pelvic inflammatory disease in woman
hepatic hemangioma
world health organization committee
postpartum
progestin component of these formulation
association between oral contraceptive use
intrahepatic cholestasis
desire
woman
available oral contraceptive combination
accelerate growth
preexist
available preparation
combativeness
erection
vomit
develop country
manufacturer of oral contraceptive product
woman with a previous history of thrombotic disease
fatiguehair
gallbladder disease
arterial thrombosis
association
nausea
early investigation of woman
retinal thrombosis
health care professional
clay color stool
oral contraceptive use
association with oral contraceptive
investigator
risk of epithelial ovarian cancer
mood change
vision change
circulatory symptom
oily skinbreast tendernessdepressiontiredness
tenderness
menstrual disorder
well differentiate hepatocellular carcinoma
myocardial infarction
weight gain
exacerbation of systemic lupus erythematosus
cardiovascular system
case of fatal pulmonary occlusive disease
unpleasant breath odor
ethinyl estradiol
bleedingincreased spottinghypomenorrhea
vaginitis
bias
glucose tolerance
skin
public health importance in the united state
unexplained shortness of breath
mistrust
possible relationship between the use of oral contraceptive
most woman
metrorrhagia
angioedema
difficulty with breathing
increase serum potassium level
termination of oral contraceptive use
depression
irritability
case of oral contraceptive induce esophageal ulceration
older formulation
appetiteweight
itch
delusion of persecution
protection against ovarian cancer
aggravation of varicose vein
urticaria
actual number of case of liver cancer in the united state
medicine
number of investigation
pulmonary embolism
postmarket experience
body
higher risk for endometrial carcinoma than other woman
suspicious papanicolaou smear
contraindication
neoplasm of the uterine cervix
spot
asthenia
candidiasis
exist cancer
liver cell adenoma
protection
careful review of a woman
experienced oligomenorrhea
incidence of hospitalization for pelvic inflammatory disease
conception delay
geographic tongue
severe lipidemia
progestin in a
last
committee of the world health organization
rapidly change mood
alteration in lipid profile
slurred speech
long term risk for mortality
antiestrogen
use of oral contraceptive
uveitis
smoke
epidermoid carcinoma
nauseaheadachemelasmahypertensionbreast tendernessedemaestrogen deficiency
significant blood pressure increase
variation in the hormonal content of oral contraceptive
use of exogenous estrogen
breakthrough bleeding
optic neuritis
normal menstrual bleeding
cholesterol level
drospirenone
overall association between oral contraceptive use
use of drospirenone
non hormonal cause of such bleeding
case of venous thrombosis
dark urine
cardiovascular risk factor before a decision
late breakthrough bleedingamenorrheahypermenorrheaestrogen
gaincholestatic jaundiceprogestin deficiency
sore throat
give product
woman on oral contraceptive combination product
development of new case of cancer
arthralgia
investigation into the epidemiology of this neoplasm
unusual tiredness
addition
observe association
decrease interest in sexual intercourse
possible diminution in lactation
pain in the chest
cry
hepatocellular carcinoma
young woman
abdominal pain
underlie
precipitation of panic disorder
nulliparous woman
risk of ovarian cancer
insufficient datum
headache
risk of breast cancer
loss of appetite
vaginal moniliasis
increase risk
early mid cycle breakthrough
mcg
numbness in the arm
pharyngitis
deficiency of the estrogen
porphyria
vomiting of blood
other western nation
gastroenteritis
urine abnormality
other risk factor
heavier menstrual period
such woman
chill
fda
rhinitis
medical attention
treated woman
unusual sense of well be
breast cancer
develop change in contact lens tolerance
oral contraceptive combination
weak association between long term use of oral contraceptive
breast pain
same committee
loss in sexual ability
vascular thrombosis
calf
strong association between oral contraceptive use
exist
hdl
complete loss of vision
groin
suspiciousness
estrogen
bronchitis
hepatic granuloma
general
upper respiratory infection
stroke
development of breast cancer
hypertension
exist vascular disease
potency of the specific estrogen
long term use
risk of endometrial cancer
risk
flu syndrome
family history of breast cancer
severity
inability
migraine
adenocarcinoma of the cervix
sinusitis
chorea
oral contraceptive user
sudden loss of coordination
weakness
finding
performance
thromboembolism
nervous system
recent large investigation of woman
young diabetic woman
firm conclusion
deficiency of these component
fever
preexist systemic disease
hepatitis b virus infection
focal nodular hyperplasia
menorrhagia
large number of confounding factor
irregular menstrual period
underlie cardiovascular disease
first several cycle of oral contraceptive use
complex alteration in plasma lipid profile
specific group of woman
progestin
relative amount
infection
iritis
increase ldl cholesterol level
accidental injury
thrombotic stroke
possible relationship between oral contraceptive use
relative risk of hepatocellular carcinoma
increase risk of dysplasia
lower risk
drive
other investigator
dizziness
amenorrhea
long term use of oral contraceptive
previous thrombotic disease
carbohydrate metabolism